Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RxC Acquisition Corp. was a Special Purpose Acquisition Company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company specifically targeted the healthcare industry, with a focus on the life sciences, medical technology, and healthcare services sectors. Led by a management team with extensive experience in pharmaceutical consulting and investment, the firm sought to identify high-growth opportunities within the global healthcare landscape. However, the company ultimately liquidated after failing to complete a business combination within its allotted timeframe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RxC Acquisition.